

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lactulose
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Cadila Pharma Launches Cadilose for Constipation, Hepatic Encephalopathy
Details : Cadilose is an advanced Lactulose formulation designed to effectively manage constipation and hepatic encephalopathy (HE).
Product Name : Cadilose
Product Type : Carbohydrate
Upfront Cash : Inapplicable
March 25, 2025
Lead Product(s) : Lactulose
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Bausch Health Announces Favorable Topline Results From Investigative Formulation of Rifaximin SSD IR
Details : In the study, the treatment arm evaluating 40 mg BID of rifaximin SSD IR plus standard of care therapy met its primary endpoint of time to resolution of OHE.
Product Name : Xifaxan
Product Type : Antibiotic
Upfront Cash : Inapplicable
March 31, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lactulose
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lactulose is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Diabetes Mellitus, Type 2.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
September 12, 2018
Lead Product(s) : Lactulose
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Lactulose
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers
Details : Lactulose is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
November 18, 2016
Lead Product(s) : Lactulose
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Lactulose
Therapeutic Area : Undisclosed
Study Phase : Phase II
Sponsor : Virginia Mason Medical Center | Cumberland Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lactulose is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
July 26, 2012
Lead Product(s) : Lactulose
Therapeutic Area : Undisclosed
Highest Development Status : Phase II
Sponsor : Virginia Mason Medical Center | Cumberland Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Lactulose
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Virginia Mason Medical Center | Cumberland Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Kristalose as Bowel Evacuant Prior to Colonoscopy
Details : Lactulose is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Carbohydrate
Upfront Cash : Inapplicable
December 08, 2010
Lead Product(s) : Lactulose
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Virginia Mason Medical Center | Cumberland Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
